#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	25654	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2095	1205.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1736	1736	T	1308	T,C	1241,10	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	25654	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2095	1205.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1470	1470	C	1489	C	1459	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46798	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3568	1295.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1763	1763	A	1472	A	1451	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46798	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3568	1295.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2397	2397	C	1466	C,T	1421,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46798	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3568	1295.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2471	2471	A	1465	A	1436	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	46798	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3568	1295.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3023	3023	C	1431	C	1411	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	55328	blaTEM	861	861	99.88	blaTEM.l6.c17.ctg.1	1609	3395.8	0	.	p	.	0	P12S	NONSYN	34	36	CCC	467	469	TCC	4430;4449;4485	T,C;C;C,T	4362,3;4356;4403,1	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	G5V	NONSYN	13	15	GGT	360	362	GTT	204;202;201	G;T;T	200;196;198	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	E12K	NONSYN	34	36	GAA	381	383	AAA	224;226;231	A,G;A;A	217,3;221;225	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	F31L	NONSYN	91	93	TTT	438	440	TTG	294;291;290	T;T,C;G,T	289;285,1;279,5	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	471	473	CAA	371;371;375	C;A;A	361;363;365	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	S75P	NONSYN	223	225	TCC	570	572	CCT	312;313;310	C;C;T	304;303;293	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	V87A	NONSYN	259	261	GTA	606	608	GCA	314;312;310	G;C,G;A,G	309;301,1;299,2	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	V130L	NONSYN	388	390	GTC	735	737	CTC	327;327;328	C,G;T;C	313,2;298;314	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	R135C	NONSYN	403	405	CGC	750	752	TGT	338;341;338	T,G,C;G,T;T,C,G	298,2,1;327,1;303,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	T137A	NONSYN	409	411	ACG	756	758	GCG	329;327;332	G;C,G;G,C	323;295,4;322,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	798	800	AAG	328;330;334	A,G,T;A;G,A	318,4,1;326;323,5	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	T152N	NONSYN	454	456	ACC	801	803	AAT	333;335;334	A;A,C;T,C	328;331,2;325,4	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	F218L	NONSYN	652	654	TTT	999	1001	TTG	235;232;230	T;T;G	232;229;229	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1029	1031	AGC	203;201;200	A;G;C	199;199;196	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1098	1100	CTG	141;139;138	C,T;T;G	135,1;124;127	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1104	1106	TCC	134;134;135	T,G;C;C	130,1;120;132	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1119	1121	GTG	160;162;162	G;T,C;G	154;147,1;158	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	2744	folP	852	852	93.78	folP.l6.c4.ctg.1	1494	181.4	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1170	1172	GCG	218;214;212	G;C,T;G	215;208,2;210	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	9208	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3342	272.0	1	SNP	p	S91F	0	.	.	271	273	TCC	539	541	TCC	299;300;306	T;C,A;C,A	296;294,1;298,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	9208	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3342	272.0	1	SNP	p	D95N	0	.	.	283	285	GAC	551	553	GAC	298;297;293	G,A;A,G,C;C	291,1;282,2,1;287	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	9208	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3342	272.0	1	SNP	p	D95G	0	.	.	283	285	GAC	551	553	GAC	298;297;293	G,A;A,G,C;C	291,1;282,2,1;287	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	2870	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1288	219.5	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	704	704	T	346	T,C	337,2	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1640	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1063	153.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	7918	parC	2304	2304	99.74	parC.l6.c17.ctg.1	2980	262.8	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1457	1459	ATC	321;316;312	A,G;T;C	305,3;308;302	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	7918	parC	2304	2304	99.74	parC.l6.c17.ctg.1	2980	262.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1610	1612	GCA	294;292;294	G,A,C;C,T;A,G,C	286,1,1;275,2;266,2,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	7918	parC	2304	2304	99.74	parC.l6.c17.ctg.1	2980	262.8	1	SNP	p	D86N	0	.	.	256	258	GAC	563	565	GAC	312;313;316	G;A;C,G	304;294;306,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	7918	parC	2304	2304	99.74	parC.l6.c17.ctg.1	2980	262.8	1	SNP	p	S87R	0	.	.	259	261	AGT	566	568	AGT	320;318;319	A,C;G;T	307,1;310;299	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	7918	parC	2304	2304	99.74	parC.l6.c17.ctg.1	2980	262.8	1	SNP	p	S87W	0	.	.	259	261	AGT	566	568	AGT	320;318;319	A,C;G;T	307,1;310;299	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	7918	parC	2304	2304	99.74	parC.l6.c17.ctg.1	2980	262.8	1	SNP	p	S87I	0	.	.	259	261	AGT	566	568	AGT	320;318;319	A,C;G;T	307,1;310;299	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	7918	parC	2304	2304	99.74	parC.l6.c17.ctg.1	2980	262.8	1	SNP	p	S88P	0	.	.	262	264	TCC	569	571	TCC	320;322;320	T;C;C	311;310;313	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	7148	parE	1986	1986	99.95	parE.l6.c17.ctg.1	2743	257.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1631	1633	GGC	338;330;329	G;G;C	331;322;322	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1267	1269	GCA	376;379;383	G;C;A,C	373;374;380,1	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1270	1272	ATC	382;382;380	A;T;C,G,A	377;378;374,1,1	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1282	1284	GTG	381;378;378	G;T;G	374;363;367	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1282	1284	GTG	381;378;378	G;T;G	374;363;367	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1786	1788	ACC	290;294;295	A;C;C	280;288;282	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1840	1842	GCG	276;276;278	G;C,G;G	260;240,2;261	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1840	1842	GCG	276;276;278	G;C,G;G	260;240,2;261	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1963	1965	GGT	220;214;210	G;G;T	217;212;206	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1972	1974	GGC	204;200;198	G;G;C	196;193;194	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	6666	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2323	282.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1990	1992	CCG	154;155;156	C,G;C;G	147,1;146;135	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	9922	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3057	320.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1596	1598	CTG	311;310;312	C,A;T,C;G	299,1;291,1;301	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4116	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1824	222.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	413	415	GGC	263;259;264	G,A;G;C	249,4;248;257	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4116	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1824	222.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	595	595	C	273	C,G	254,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	4976	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1394	346.6	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	864	864	T	357	T	338	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	4976	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1394	346.6	1	SNP	p	G120K	0	.	.	358	360	GGT	591	593	GGT	347;343;343	G,A;G,A;T,G,A	337,3;334,3;312,4,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	4976	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1394	346.6	1	SNP	p	A121N	0	.	.	361	363	GCC	594	596	GCC	344;346;348	G,A,T;C,A;C	330,3,1;335,4;344	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	4976	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1394	346.6	1	SNP	p	A121D	0	.	.	361	363	GCC	594	596	GCC	344;346;348	G,A,T;C,A;C	330,3,1;335,4;344	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	17200	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4932	344.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1954	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1161	166.6	1	SNP	p	V57M	1	.	.	169	171	ATG	609	611	ATG	372;372;374	A;T;G	364;364;365	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
